Filing Details

Accession Number:
0001140361-22-031345
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-29 17:37:20
Reporting Period:
2022-08-25
Accepted Time:
2022-08-29 17:37:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
926617 Aspira Women's Health Inc. AWH In Vitro & In Vivo Diagnostic Substances (2835) 330595156
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1021412 W Jack Schuler 100 N. Field Drive
Suite 360
Lake Forest IL 60045
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Acquisiton 2022-08-25 133,333 $0.00 25,527,850 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $0.001 Warrants (Right to buy) Acquisiton 2022-08-25 133,333 $0.00 133,333 $0.88
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
133,333 2022-08-25 2027-08-25 No 4 P Indirect
Footnotes
  1. Each share of common stock was purchased together with one warrant to purchase one share of common stock (each share and related warrant, a "unit"), at a price of $0.75 per unit.
  2. These shares of common stock and warrants are directly held by the Jack W. Schuler Living Trust. Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.
  3. The terms of the warrants prohibit the holder from exercising the warrants to the extent that the exercise would result in the holder and its affiliates beneficially owning more than 4.99% (or, at the election of the holder and after 61 days' advance notice to the Issuer, 9.99%) of the outstanding shares of common stock. As such, as of the date of the filing of this Form 4, none of the warrants owned by the Reporting Person are currently exercisable.